NCT00242918View on ClinicalTrials.gov

Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

November 30, 2007

Conditions
Prostate Cancer
Interventions
DRUG

docetaxel

DRUG

ZD1839

Trial Locations (1)

98101

Virginia Mason Medical Center, Seattle

Sponsors

Collaborators (2)

AstraZeneca
Sanofi
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Sanofi

INDUSTRY

lead

Benaroya Research Institute

OTHER